Abstract:Cardiac arrhythmias cause significant morbidity and mortality and pose a major public health problem. They arise from disruptions in the normally orderly propagation of cardiac electrophysiological activation and recovery through successive cardiomyocytes in the heart. They reflect abnormalities in automaticity, initiation, conduction, or recovery in cardiomyocyte excitation. The latter properties are dependent on surface membrane electrophysiological mechanisms underlying the cardiac action potential. Their disruption results from spatial or temporal instabilities and heterogeneities in the generation and propagation of cellular excitation. These arise from abnormal function in their underlying surface membrane, ion channels, and transporters, as well as the interactions between them. The latter, in turn, form common regulatory targets for the hierarchical network of diverse signaling mechanisms reviewed here. In addition to direct molecular-level pharmacological or physiological actions on these surface membrane biomolecules, accessory, adhesion, signal transduction, and cytoskeletal anchoring proteins modify both their properties and localization. At the cellular level of excitation–contraction coupling processes, Ca 2+ homeostatic and phosphorylation processes affect channel activity and membrane excitability directly or through intermediate signaling. Systems -level autonomic cellular signaling exerts both acute channel and longer-term actions on channel expression. Further upstream intermediaries from metabolic changes modulate the channels both themselves and through modifying Ca 2+ homeostasis. Finally, longer-term organ -level inflammatory and structural changes, such as fibrotic and hypertrophic remodeling, similarly can influence all these physiological processes with potential pro-arrhythmic consequences. These normal physiological processes may target either individual or groups of ionic channel species and alter with particular pathological conditions. They are also potentially alterable by direct pharmacological action, or effects on longer-term targets modifying protein or cofactor structure, expression, or localization. Their participating specific biomolecules, often clarified in experimental genetically modified models, thus constitute potential therapeutic targets. The insights clarified by the physiological and pharmacological framework outlined here provide a basis for a recent modernized drug classification. Together, they offer a translational framework for current drug understanding. This would facilitate future mechanistically directed therapeutic advances, for which a number of examples are considered here. The latter are potentially useful for treating cardiac, in particular arrhythmic, disease.

Caveolin-3 and Arrhythmias: Insights into the Molecular Mechanisms

Enhanced Basal Activity of a Cardiac Ca2+ Release Channel (ryanodine Receptor) Mutant Associated with Ventricular Tachycardia and Sudden Death.

Caveolin-3 and Caveolin-1 Interaction Decreases Channel Dysfunction Due to Caveolin-3 Mutations

Cardiac-Specific Overexpression of Caveolin-1 in Rats with Ischemic Cardiomyopathy Improves Arrhythmogenicity and Cardiac Remodeling

The Kir2.1-Na V 1.5 Channelosome and its role in Arrhythmias in Inheritable Cardiac Diseases

Abnormal Ca2+ Homeostasis, Atrial Arrhythmogenesis, and Sinus Node Dysfunction in Murine Hearts Modeling RyR2 Modification

Caveolin-3 Negatively Regulates Recombinant Cardiac K(ATP) Channels.

Caveolin-3 negatively regulates endocytic recycling of cardiac KATP channels

Cardiac arrhythmogenesis: roles of ion channels and their functional modification

Molecular biology of K(+) channels and their role in cardiac arrhythmias.

Discovery and Characterization of a Monogenetic Insult, Caveolin-3-v37l, That Precipitated Oligo-Proteomic Perturbations Governing Repolarization Reserve.

Caveolin-1/-3: therapeutic targets for myocardial ischemia/reperfusion injury

Sarcoplasmic Reticulum Ca<SUP>2+</SUP> Dysregulation in the Pathophysiology of Inherited Arrhythmia: An Update

Ca2+-dependent modulation of voltage-gated myocyte sodium channels

Pro-Arrhythmogenic Effects of Cacna1c G1911r Mutation in Human Ventricular Tachycardia: Insights from Cardiac Multi-Scale Models

Pathophysiology and Molecular Mechanism of Caveolin Involved in Myocardial Protection Strategies in Ischemic Conditioning.

The Importance of Caveolin As a Target in the Prevention and Treatment of Diabetic Cardiomyopathy

Sarcoplasmic Reticulum Ca2+ Dysregulation in the Pathophysiology of Inherited Arrhythmia: an Update

Computational Cardiac Modeling Reveals Mechanisms of Ventricular Arrhythmogenesis in Long QT Syndrome Type 8: CACNA1C R858H Mutation Linked to Ventricular Fibrillation

Regulation of Cardiovascular and Cardiac Functions by Caveolins

Functional Roles of Cav1.3(alpha1D) Calcium Channels in Atria: Insights Gained from Gene-Targeted Null Mutant Mice.